[at The Wall Street Journal] – Sprint said its fourth-quarter loss narrowed, with higher subscriber rolls boosting the cellphone carrier’s revenue. moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]
[Reuters – UK Focus] – The U.S. Food and Drug Administration said it will review possible heart risks associated with AstraZeneca Plc (NYSE: AZN – news) ‘s widely-used diabetes drug saxagliptin, marketed as Onglyza and Kombiglyze XR. The health regulator moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is […]
[Telegraph] – In the first of a regular series of fund suggestions for this year’s Isa, we name some of the top choices in the UK income sector moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]
moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]
[at noodls] – AstraZeneca and BIND Therapeutics announced today that they have entered into a strategic collaboration to develop and commercialise an Accurinâ„¢, a targeted and programmable cancer nanomedicine from BIND’s … moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]
[at noodls] – AstraZeneca today announced that it has entered into a settlement agreement in its US patent infringement litigation against Watson Laboratories, Inc., Actavis, Inc. (formerly known as Watson Pharmaceuticals, … moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]
[at noodls] – AstraZeneca today announced that an analysis of data from real world study PATHOS, published in the Journal of Internal Medicine, show that chronic obstructive pulmonary disease (COPD) patients treated … moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]
[at noodls] – AstraZeneca today announced its intention to establish a new global R&D centre and corporate headquarters in Cambridge in the UK by 2016. The planned investment of around £330 million ($500 million) to … moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here […]
[ACN Newswire] – By David MoskowitzThursday morning, Israeli financial newspaper Calcalist is reporting that Teva Pharmaceuticals (NASDAQ:TEVA) and AstraZeneca (NYSE:AZN) are leading candidates among other large drug companies … moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – AstraZeneca and Bristol-Myers Squibb Company today announced that the European Commission has approved FORXIGAâ„¢ (dapagliflozin) tablets for the treatment of type 2 diabetes in the European Union (EU). … moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboard […]
